Muhammad Umair Mushtaq, Associate Professor of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, shared a post on X about a paper he co-authored with colleagues, published in Clinical Lymphoma Myeloma and Leukemia:
“Impact of MRD on outcomes after allo-HCT for AML.”
Title: Impact of Measurable Residual Disease Status on Outcomes after HLA-Matched Donor Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Authors: Moazzam Shahzad, Muhammad Kashif Amin, Sohaib Irfan, Abhinav Vyas, Rania Ahsan, Sibgha Gull Chaudhary, Iqra Anwar, Matthew McGuirk, Raheel Iftikhar, Haitham Abdelhakim, Anurag K. Singh, Mehdi Hamadani, Joseph P. Mcguirk, Muhammad Umair Mushtaq
You can read the Full Article in Clinical Lymphoma Myeloma and Leukemia.
More posts featuring Muhammad Umair Mushtaq on OncoDaily.